Efficacy and safety of selexipag, an oral prostacyclin receptor agonist for the treatment of pulmonary hypertension: A meta-analysis.

Chen, Minshan; Lai, Yuanqiang; Chen, Riken; Lu, Jianmin; Zhang, Yu; Liu, Haimin; Wang, Donghao; Zhong, Yue; Zheng, Zhenzhen; Hong, Cheng

Chen, Minshan; Lai, Yuanqiang; Chen, Riken; Lu, Jianmin; Zhang, Yu; Liu, Haimin; Wang, Donghao; Zhong, Yue; Zheng, Zhenzhen; Hong, Cheng.

Afiliação

Chen M; China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, China; Department of Clinical Medicine, The First Clinical School of Guangzhou Medical University, China.
Lai Y; China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, China; Department of Clinical Medicine, The First Clinical School of Guangzhou Medical University, China.
Chen R; China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, China.
Lu J; China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, China.
Zhang Y; China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, China.
Liu H; China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, China.
Wang D; China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, China.
Zhong Y; China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, China.
Zheng Z; Department of Respiration, The Second Affiliated Hospital of Guangdong Medical University, China. Electronic address: 3342227603@qq.com.
Hong C; China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, China. Electronic address: gyfyyhc@126.com.

Pulm Pharmacol Ther ; 72: 102100, 2022 02.

Article em En | MEDLINE | ID: mdl-34856365

Assuntos

Anti-Hipertensivos; Hipertensão Pulmonar; Receptores de Epoprostenol; Acetamidas/efeitos adversos; Anti-Hipertensivos/efeitos adversos; Humanos; Hipertensão Pulmonar/tratamento farmacológico; Pirazinas; Receptores de Epoprostenol/agonistas

Palavras-chave

Drug treatment; Meta-analysis; Pulmonary arterial hypertension; Safety; Selexipag

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Epoprostenol / Hipertensão Pulmonar / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Revista: Pulm Pharmacol Ther Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google